Analyst Rating: Will Generation Bio Co (GBIO) Stock Do Better Than the Market?

Wall Street is positive on Generation Bio Co (GBIO). On average, analysts give the stock a Buy rating. The average price target is $8.8, which means analysts expect the stock to climb by 475.16% over the next twelve months. That average ranking earns the stock an Analyst Rating of 33, which is better than 33% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating GBIO a Buy today. Find out what this means to you and get the rest of the rankings on GBIO!

See Full GBIO Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Generation Bio Co Stock Today?

Generation Bio Co (GBIO) stock is trading at $1.53 as of 12:23 PM on Friday, Dec 1, a gain of $0.40, or 35.35% from the previous closing price of $1.13. The stock has traded between $1.13 and $1.56 so far today. Volume today is above average. So far 1,625,373 shares have traded compared to average volume of 993,790 shares. Click Here to get the full Stock Report for Generation Bio Co stock.